Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
03/2003
03/18/2003US6534546 Aniline derivatives possessing an inhibitory effect of nitric oxide synthase
03/18/2003US6534535 Inhibitors of factor Xa
03/18/2003US6534524 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
03/18/2003US6534521 Useful in the treatment of inflammation, atherosclerosis, restenosis, and immune disorders such as arthritis and transplant rejection
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003US6534250 Photo-reactive benzocyclobutenones and polymers thereform for self-photocuring, photo-crosslinking and photopatterning without catalysts
03/18/2003US6534041 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/13/2003WO2003020688A1 Selective protein tyrosine phosphatase inhibitors
03/13/2003WO2003020677A2 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments
03/13/2003WO2003020280A2 Compositions and use thereof in the treatment of cancer
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003WO2002066427A3 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof
03/13/2003WO2002050019A3 Diamines as modulators of chemokine receptor activity
03/13/2003WO2002046149A3 2-thio-5-amino substituted benzoquinones, their manufacture and their use in rubber
03/13/2003WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
03/13/2003WO2002024194A3 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
03/13/2003US20030050325 Novel compounds of the indolecarboxylic family and use thereof
03/13/2003US20030050320 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity
03/13/2003US20030050307 Treating certain psychiatric and neurological disorders; anxiety disorder, panic disorder, obsessive compulsive disorder, depression, social phobia and eating disorders, and psychosis
03/13/2003US20030050288 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; oral contraception using multiphase progestotational agents, antiprogestins, indole or thiophene derivatives and placebo
03/13/2003US20030050248 Novel amino acid and peptide inhibitors of Staphylococcus virulence
03/13/2003CA2459584A1 Compositions and use thereof in the treatment of cancer
03/13/2003CA2458399A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
03/12/2003EP1291341A1 Compounds exhibiting thrombopoietin-like activities
03/12/2003EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a)
03/12/2003EP1289952A1 Indole derivatives with vascular damaging activity
03/12/2003EP1289951A1 Growth hormone secretagogues
03/12/2003EP1036058B1 Adamantane derivatives
03/12/2003EP0977730B1 Amino acid derivatives inhibiting extracellular matrix metalloproteinase and tnf alpha release
03/12/2003EP0964852B1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/12/2003EP0937726B1 Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates
03/12/2003EP0923548B1 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht 1a ligands
03/12/2003EP0907639B1 Polymorphic compounds
03/12/2003EP0873325B1 Process for producing guanidine derivatives, intermediates therefor and their production
03/12/2003EP0871612B1 Fused isoindolones as inhibitors of protein kinase c
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1402707A Trifluoromethyl-substd. spirocyclic ketoenols
03/12/2003CN1401631A Bis (amino carbonylnaphthol) derivs.
03/12/2003CN1401629A Image forming agent, its precursor and preparing process thereof
03/12/2003CN1401231A Plant rooting promoter and treatment method thereof
03/11/2003WO2002022578A1 (2-azabicyclo[2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists
03/11/2003US6531612 Nitrile derivatives that inhibit cathepsin K
03/11/2003US6531502 3-Methylidenyl-2-indolinone modulators of protein kinase
03/11/2003US6531491 Methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis,
03/11/2003US6531485 Prostaglandin agonists
03/11/2003CA2421936A1 (2-azabicyclo[2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists
03/11/2003CA2242351C Novel tricyclic compounds and drug compositions containing the same
03/11/2003CA2210675C New anti-free radical melatonin derivatives and the compounds which contain them
03/06/2003WO2003019697A2 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
03/06/2003WO2003018555A1 Process for the preparation of indole derivatives
03/06/2003WO2003018553A1 Oral antidiabetic agents
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/06/2003WO2003018004A2 Analgetic pyrroline derivatives
03/06/2003WO2003017927A2 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
03/06/2003WO2003017765A1 Treatment for cystic fibrosis
03/06/2003WO2003017764A1 Substituted propargylamines
03/06/2003WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/06/2003WO2002094770A3 Aminoalcohol derivatives
03/06/2003WO2002024672A3 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
03/06/2003WO2002000650A9 Novel compounds possessing antibacterial, antifungal or antitumor activity
03/06/2003US20030045755 Polyamine analogues as cytotoxic agents
03/06/2003US20030045744 Preparing the chemical intermediate of perindopril, by reacting sodium pyruvate with a salt of norvalinates, catalyzing the hydrogenation in presence of palladium on carbon, acidification, filtration
03/06/2003US20030045728 Indol-3-yl derivatives
03/06/2003US20030045727 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups
03/06/2003US20030045567 (-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
03/06/2003US20030045564 Saururus chinensis extract for prevention and treatment of neurodegenerative disease
03/06/2003US20030045560 6-(Aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
03/06/2003US20030045527 Treating central nervous system or gastrointestinal disorders
03/06/2003US20030045518 Certain bis(thio-hydrazide amide) compounds significantly enhance the anticancer activity of taxol.
03/06/2003US20030045432 Phenyl-substituted cyclic ketoenols
03/06/2003CA2458621A1 Oral antidiabetic agents
03/06/2003CA2458217A1 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
03/06/2003CA2458015A1 Analgetic pyrroline derivatives
03/06/2003CA2455842A1 Process for the preparation of indole derivatives
03/05/2003EP1288275A2 Electrochromic solution containing a hydrazone compound and device manufactured with same
03/05/2003EP1288203A1 Cyclic nitrones and pharmaceutical compositions containing them
03/05/2003EP1288199A1 Mmp-12 inhibitors
03/05/2003EP1287404A1 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
03/05/2003EP1286964A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
03/05/2003EP1286672A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003EP1079826B1 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases
03/05/2003EP0964865B1 Pharmaceutically active tricyclic amines
03/05/2003CN1400974A Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors
03/05/2003CN1400969A Fused imidazolium derivatives
03/05/2003CN1102388C Inhibition of smooth muscle migration and proliferation with hydrogen carbazole compounds
03/04/2003US6528687 Hydrogenation of an imine in the presence of a base and, a ruthenium complex of a chiral diphosphine and diamine catalyst
03/04/2003US6528661 Providing atorvastatin ester derivative; converting the atorvastatin ester derivative to atorvastatin hemi-calcium with calcium hydroxide
03/04/2003US6528657 For use in electroluminescence light emission element and can emit lights of various colors when an energy such as electric energy or electromagnetic energy is applied thereto
03/04/2003US6528655 Aromatic derivatives with HIV integrase inhibitory properties
03/04/2003US6528650 Cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing
03/04/2003US6528532 Benzenesulfonamide group
03/04/2003US6528525 Amidocarboxylic acid derivatives
03/04/2003US6528510 HIV protease inhibitors
03/04/2003US6528455 Phenoxy-and thiophenoxy acrylic acid compounds as herbicides
03/04/2003CA2401309A1 Electrochromic solution containing hydrazone compound and device manufactured with same
03/03/2003WO2002020491A1 Arylpiperazine derivatives and their use as psychotropic agents
03/03/2003CA2421219A1 Arylpiperazine derivatives and their use as psychopharmaceuticals
02/2003
02/27/2003WO2003016317A1 Processes for preparing calcium salt forms of statins
1 ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 ... 458